OpenAlex
PricingAboutJobs
Log inGet started
Work

Metrifonate treatment of the cognitive deficits of Alzheimer's disease

HTML

Year: 1998
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Neurology
DOI: 10.1212/wnl.50.5.1214
Authors: J. L. Cummings, P. A. Cyrus, F. Bieber, J. Mas, J. Orazem, B. Gulanski, The Metrifonate Study Group*
Institutions: University of California, Los Angeles, VA West Los Angeles Medical Center
Language: English

Topic: Cholinesterase and Neurodegenerative Diseases
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: trichlorfon, Alzheimer's disease, acetylcholinesterase inhibitors, cognitive impairment, dose-finding, ADAS-Cog, CIBIC-Plus, global function, drug safety, gastrointestinal adverse effects, hepatotoxicity
SDG: Good health and well-being

Open Access status: closed

Funder: Bayer Corporation
OpenAlex ID: W2023054003
FWCI: 24.26
Cites: 32
Cited by: 184
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms